Difference between revisions of "AstraZeneca"
Jump to navigation
Jump to search
m (SW: reformat ref) |
m (SW: formatting) |
||
| Line 1: | Line 1: | ||
{{#badges: GlobalCorpWiki}} | {{#badges: GlobalCorpWiki}} | ||
| − | '''AstraZeneca''' is one of the world's largest pharmaceutical companies. The company specialises in drugs for gastrointestinal, cardiovascular | + | '''AstraZeneca''' is one of the world's largest [[pharmaceutical companies]]. The company specialises in drugs for gastrointestinal, cardiovascular and oncology. |
==Animal testing== | ==Animal testing== | ||
| − | AstraZeneca does [[animal testing]]. | + | AstraZeneca does [[animal testing]]. <ref>[http://www.afadvisor.org/content/aboutAZ/investing/corporateResponsibility/default/astrazeneca-clinical-trials.asp Clinical Trials], AstraZeneca, accessed February 2009</ref> |
| − | <ref>[http://www.afadvisor.org/content/aboutAZ/investing/corporateResponsibility/default/astrazeneca-clinical-trials.asp Clinical Trials], AstraZeneca, accessed February 2009</ref> | ||
=== Contract testing === | === Contract testing === | ||
| Line 13: | Line 12: | ||
==Public relations & lobbying== | ==Public relations & lobbying== | ||
| − | [[Americans for Medical Progress]]'s (AMP) board of directors consists of senior executives and other representatives employed by the pharmaceutical and vivisection industries. Board members represent multinational, billion dollar corporations as well as universities and institutions receiving government grants for vivisection. They include: [[Charles River]], [[Abbott Laboratories]], [[GlaxoSmithKline]], [[Pfizer]], | + | [[Americans for Medical Progress]]'s (AMP) board of directors consists of senior executives and other representatives employed by the pharmaceutical and vivisection industries. Board members represent multinational, billion dollar corporations as well as universities and institutions receiving government grants for vivisection. They include: [[Charles River]], [[Abbott Laboratories]], [[GlaxoSmithKline]], [[Pfizer]], AstraZeneca and [[Wyeth]]. <ref>[http://www.amprogress.org/site/c.jrLUK0PDLoF/b.1086423/k.65B3/AMP_BOARD_OF_DIRECTORS.htm Board of Directors], [[Americans for Medical Progress]], accessed February 2009</ref> |
The company spent $2,840,000 for [[lobbying]] in 2006. In-house lobbyists along with 6 [[lobbying firms]] were used, including [[Mehlman Vogel Castagnetti]]. <ref>[http://www.opensecrets.org/lobbyists/clientsum.asp?txtname=AstraZeneca&year=2006 AstraZeneca lobbying expenses], ''Open Secrets''.</ref> | The company spent $2,840,000 for [[lobbying]] in 2006. In-house lobbyists along with 6 [[lobbying firms]] were used, including [[Mehlman Vogel Castagnetti]]. <ref>[http://www.opensecrets.org/lobbyists/clientsum.asp?txtname=AstraZeneca&year=2006 AstraZeneca lobbying expenses], ''Open Secrets''.</ref> | ||
| Line 19: | Line 18: | ||
==Political contributions== | ==Political contributions== | ||
| − | AstraZeneca gave $379,320 to federal candidates in the 2006 election through its [[political action committee]] - 28% to [[Democrats]] and 72% to [[Republican Party (USA)|Republicans]]. | + | AstraZeneca gave $379,320 to federal candidates in the 2006 election through its [[political action committee]] - 28% to [[Democrats]] and 72% to [[Republican Party (USA)|Republicans]]. <ref>[http://www.opensecrets.org/pacs/lookup2.asp?strID=C00279455 2006 PAC Summary Data], ''Open Secrets'', accessed August 2007.</ref> |
| − | <ref>[http://www.opensecrets.org/pacs/lookup2.asp?strID=C00279455 2006 PAC Summary Data], ''Open Secrets'', accessed August 2007.</ref> | ||
==Corporate Donations== | ==Corporate Donations== | ||
| Line 41: | Line 39: | ||
==Contact details== | ==Contact details== | ||
| + | AstraZeneca | ||
15 Stanhope Gate<br> | 15 Stanhope Gate<br> | ||
London<br> | London<br> | ||
W1K 1LN, United Kingdom<br> | W1K 1LN, United Kingdom<br> | ||
| + | |||
Phone: +44-20-7304-5000<br> | Phone: +44-20-7304-5000<br> | ||
| + | |||
Fax: +44-20-7304-5151<br> | Fax: +44-20-7304-5151<br> | ||
| − | Web: http://www.astrazeneca.com | + | |
| + | Web address: http://www.astrazeneca.com | ||
==Articles & sources== | ==Articles & sources== | ||
===SourceWatch articles=== | ===SourceWatch articles=== | ||
| + | * [[Animal testing]] | ||
| + | * [[American Cancer Society]] | ||
* [[Americans for Medical Progress]] | * [[Americans for Medical Progress]] | ||
| + | * [[Huntingdon Life Sciences]] | ||
| + | * [[Pharmaceutical industry]] | ||
* [[War on Cancer]] | * [[War on Cancer]] | ||
| − | |||
| − | |||
| − | |||
| − | |||
===References=== | ===References=== | ||
| Line 62: | Line 64: | ||
=== External links === | === External links === | ||
| − | *Heather Thomlinson, [http://www.guardian.co.uk/business/story/0,3604,1332957,00.html "European market is inferior, says AstraZeneca"], ''Guardian'' (UK), October 22, 2004. | + | * Heather Thomlinson, [http://www.guardian.co.uk/business/story/0,3604,1332957,00.html "European market is inferior, says AstraZeneca"], ''Guardian'' (UK), October 22, 2004. |
| − | *"[http://www.prweek.com/news/news_worldwire.cfm?ID=238147&site=1 AZ raises Crestor global PR clout]", ''PR Week'', May 20, 2005. (Sub req'd). (This article refers to AZ's PR team handling the controversy over its cholesterol-lowering drug Crestor.) | + | * "[http://www.prweek.com/news/news_worldwire.cfm?ID=238147&site=1 AZ raises Crestor global PR clout]", ''PR Week'', May 20, 2005. (Sub req'd). (This article refers to AZ's PR team handling the controversy over its cholesterol-lowering drug Crestor.) |
| − | *Peter Rost, MD, "[http://www.counterpunch.org/rost04182007.html The Strange Profits from a Re-Branded Cancer Drug: How to Sell Drugs at $4,200 a Dose]", | + | * Peter Rost, MD, "[http://www.counterpunch.org/rost04182007.html The Strange Profits from a Re-Branded Cancer Drug: How to Sell Drugs at $4,200 a Dose]", [[Counterpunch]], April 18, 2007. |
| − | *Stephenie Edwards [http://www.hsus.org/animals_in_research/animals_in_research_news/outsourcing_of_primate.html Outsourcing of Primate Research Puts Animal Welfare in Question], Humane Society of the | + | * Stephenie Edwards [http://www.hsus.org/animals_in_research/animals_in_research_news/outsourcing_of_primate.html Outsourcing of Primate Research Puts Animal Welfare in Question], [[Humane Society of the United States]], July 2006 |
[[Category: Corporations]][[Category: Pharmaceutical industry]][[Category: Animal testing]] [[Category: Huntingdon Life Sciences]] | [[Category: Corporations]][[Category: Pharmaceutical industry]][[Category: Animal testing]] [[Category: Huntingdon Life Sciences]] | ||
Revision as of 19:18, 4 December 2009
{{#badges: GlobalCorpWiki}}
AstraZeneca is one of the world's largest pharmaceutical companies. The company specialises in drugs for gastrointestinal, cardiovascular and oncology.
Contents
Animal testing
AstraZeneca does animal testing. [1]
Contract testing
AstraZeneca contract tests out to Huntingdon Life Sciences (HLS). [2] Huntingdon Life Sciences is the 3rd largest contract research organization (CRO) in the world and the largest animal testing facility in all of Europe. Firms hire HLS to conduct animal toxicity tests for agrochemicals, petrochemicals, household products, pharmaceutical drugs and toxins. [3] HLS has a long history of gross animal welfare violations. See also Huntingdon Life Sciences, sections 2 & 3.
Public relations & lobbying
Americans for Medical Progress's (AMP) board of directors consists of senior executives and other representatives employed by the pharmaceutical and vivisection industries. Board members represent multinational, billion dollar corporations as well as universities and institutions receiving government grants for vivisection. They include: Charles River, Abbott Laboratories, GlaxoSmithKline, Pfizer, AstraZeneca and Wyeth. [4]
The company spent $2,840,000 for lobbying in 2006. In-house lobbyists along with 6 lobbying firms were used, including Mehlman Vogel Castagnetti. [5]
Political contributions
AstraZeneca gave $379,320 to federal candidates in the 2006 election through its political action committee - 28% to Democrats and 72% to Republicans. [6]
Corporate Donations
They Donate their products to AmeriCares. [1]
Personnel
Key executives and 2006 pay: [7]
- David R. Brennan, Chief Executive Officer and Executive Director, $3,210,000
- John Patterson, Executive Director of Drug Development, $ 1,580,000
- David Smith, Executive Vice President of Operations
Selected board members: [8]
- Louis Schweitzer, Non-Executive Chairman, Chairman of the Nomination Committee
- Jane Henney, Non-Executive Director
- Marcus Wallenberg, Non-Executive Director
Contact details
AstraZeneca
15 Stanhope Gate
London
W1K 1LN, United Kingdom
Phone: +44-20-7304-5000
Fax: +44-20-7304-5151
Web address: http://www.astrazeneca.com
Articles & sources
SourceWatch articles
- Animal testing
- American Cancer Society
- Americans for Medical Progress
- Huntingdon Life Sciences
- Pharmaceutical industry
- War on Cancer
References
- ↑ Clinical Trials, AstraZeneca, accessed February 2009
- ↑ Inside Customers, Inside Huntingdon Life Sciences, accessed December 2008
- ↑ Frequently Asked Questions About Huntingdon Life Sciences, Inside HLS, accessed February 2009
- ↑ Board of Directors, Americans for Medical Progress, accessed February 2009
- ↑ AstraZeneca lobbying expenses, Open Secrets.
- ↑ 2006 PAC Summary Data, Open Secrets, accessed August 2007.
- ↑ AstraZeneca Key Executives, Yahoo Finance, accessed August 2007.
- ↑ Board of Directors, AstraZeneca, accessed August 2007.
External links
- Heather Thomlinson, "European market is inferior, says AstraZeneca", Guardian (UK), October 22, 2004.
- "AZ raises Crestor global PR clout", PR Week, May 20, 2005. (Sub req'd). (This article refers to AZ's PR team handling the controversy over its cholesterol-lowering drug Crestor.)
- Peter Rost, MD, "The Strange Profits from a Re-Branded Cancer Drug: How to Sell Drugs at $4,200 a Dose", Counterpunch, April 18, 2007.
- Stephenie Edwards Outsourcing of Primate Research Puts Animal Welfare in Question, Humane Society of the United States, July 2006
